Theratechnologies Inc.

NASDAQ: THTX · Real-Time Price · USD
3.24
0.02 (0.62%)
At close: Aug 15, 2025, 3:06 PM

Theratechnologies Income Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Revenue
84.38M 88.67M 85.87M 84.32M 82.57M 78.1M 81.76M 79.73M 79.69M 81.41M 80.06M 77.39M 74.43M 72.95M 69.82M 70.19M 66.39M 65.76M
Cost of Revenue
18.8M 18.65M 20.45M 19.42M 19.86M 20.23M 19.64M 20.48M 20.8M 24.87M 26.28M 26.78M 26.99M 23.95M 23.26M 23.5M 24.11M 25.55M
Gross Profit
65.58M 70.02M 65.42M 64.9M 62.71M 57.88M 62.13M 59.26M 58.89M 56.53M 53.78M 50.61M 47.44M 49M 46.56M 46.69M 42.28M 40.21M
Operating Income
7.12M 12.31M 8.17M 9.93M 3.77M -7.47M -10.63M -19M -24.58M -37.59M -39.91M -42.27M -43.98M -28.37M -25.24M -21.28M -20.01M -19.15M
Interest Income
785K 1.07M 1.48M 1.29M 1.1M 963.08K 770.08K 747K 652K 497K 316K 223K 216K 216K 195K 164.34K 132.34K 159.35K
Pretax Income
-6.83M -1.51M -6.3M -2.1M -6.57M -17.56M -23.54M -28.64M -35.42M -48.14M -46.79M -48.89M -50.98M -34.75M -31.66M -27.31M -24.59M -24.02M
Net Income
-9.16M -3.71M -8.31M -3.16M -7M -18M -23.96M -29.13M -35.93M -48.65M -47.24M -49.21M -51.17M -34.84M -31.73M -27.37M -24.63M -24.05M
Selling & General & Admin
44.38M 41.51M 40.27M 38.66M 39.84M 40.58M 42.39M 43.66M 45.84M 55.84M 56.75M 56.71M 55.39M 45.98M 43.52M 41.58M 40.02M 39.88M
Research & Development
14.08M 16.19M 16.97M 16.32M 19.1M 24.77M 30.37M 34.6M 37.63M 38.29M 36.94M 36.16M 36.03M 31.39M 28.27M 26.39M 22.28M 19.48M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
58.46M 57.7M 57.24M 54.97M 58.94M 65.34M 72.76M 78.26M 83.46M 94.13M 93.69M 92.87M 91.42M 77.37M 71.8M 67.97M 62.29M 59.36M
Interest Expense
7.31M 8.9M 10.42M 10.85M 10.93M 10.72M 10.39M 9.8M 8.62M 7.51M 6.51M 5.64M 5.54M 5.6M 5.66M 5.7M 5.56M 5.52M
Selling & Marketing Expenses
26.66M 26.19M 25.42M 25.12M 25.54M 25.66M 26.77M 27.83M 29.51M 38.4M 39.39M 39.77M 39.03M 30.56M 28.91M 27.25M 26.62M 26.66M
Cost & Expenses
77.25M 76.35M 77.69M 74.39M 78.81M 85.57M 92.39M 98.74M 104.27M 119M 119.97M 119.66M 118.42M 101.32M 95.06M 91.47M 86.4M 84.91M
Income Tax Expense
2.33M 2.2M 2M 1.06M 427K 435K 421K 491K 516K 512K 443K 319K 186K 84K 63K 60K 42K 22K
Shares Outstanding (Basic)
49.36M 49.36M 51.52M 51.52M 49.36M 49.36M 73.08M 73.08M 96.81M 96.81M 95.13M 95.13M 95.12M 95.12M 95.12M 94.95M 94.5M 84.69M
Shares Outstanding (Diluted)
49.36M 50.4M 49.37M 49.37M 49.37M 49.36M 73.08M 73.08M 96.81M 96.81M 95.13M 95.13M 95.12M 95.12M 95.12M 94.95M 94.5M 84.69M
EPS (Basic)
-0.18 -0.07 -0.16 -0.05 -0.12 -0.24 -0.26 -0.3 -0.37 -0.51 -0.5 -0.51 -0.53 -0.36 -0.34 -0.3 -0.29 -0.3
EPS (Diluted)
-0.19 -0.08 -0.17 -0.05 -0.12 -0.24 -0.26 -0.3 -0.37 -0.51 -0.5 -0.51 -0.53 -0.36 -0.34 -0.3 -0.29 -0.3
EBITDA
2.05M 9.15M 5.91M 10.59M 4.81M -6.13M -12.01M -17.31M -23.14M -29.4M -27.81M -29.53M -30.39M -20.4M -17.25M -12.91M -10.32M -9.91M
EBIT
186K 6.58M 3.31M 7.91M 1.75M -8.94M -15.24M -20.91M -26.8M -40.63M -40.28M -43.25M -45.45M -29.15M -26M -21.66M -19.07M -18.58M
Depreciation & Amortization
1.86M 2.57M 2.59M 2.68M 3.06M 2.81M 3.23M 3.6M 3.67M 11.23M 12.47M 13.72M 15.05M 8.75M 8.75M 8.75M 8.75M 8.68M